THERMO FISHER SCIENTIFIC INC.
For the period ended Mar 28, 2026. Filed May 1, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 28, 2026 · Filed May 1, 2026
TMO$718.20-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
| Three months ended | ||
|---|---|---|
| March 28, | March 29, | |
| (In millions) | 2026 | 2025 |
| Comprehensive income/(loss) | ||
| Net income | $1,656 | $1,511 |
| Other comprehensive income/(loss): | ||
| Cumulative translation adjustment: | ||
| Cumulative translation adjustment (net of tax provision (benefit) of $27 and $(207)) | (58) | 360 |
| Unrealized gains/(losses) on hedging instruments: | ||
| Reclassification adjustment for losses included in net income (net of tax (provision) benefit of $0 and $0) | 1 | 1 |
| Pension and other postretirement benefit liability adjustments: | ||
| Pension and other postretirement benefit liability adjustments arising during the period (net of tax (provision) benefit of $(1) and $1) | 2 | (3) |
| Amortization of net loss included in net periodic pension cost (net of tax (provision) benefit of $0 and $0) | 1 | 1 |
| Total other comprehensive income/(loss) | (55) | 358 |
| Comprehensive income/(loss) | 1,601 | 1,869 |
| Less: comprehensive income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest | (1) | 8 |
| Comprehensive income attributable to Thermo Fisher Scientific Inc. | $1,602 | $1,861 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.